Co-targeting CDK2 and CDK9 inhibits MYC oncogenic programs and has anti-tumor effects in CIC-rearranged sarcoma
- DOI
- 10.1038/s43856-026-01956-1
- Published
- 2026-10-07
- Container
- Communications Medicine
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s43856-026-01956-1,
title = {Co-targeting CDK2 and CDK9 inhibits MYC oncogenic programs and has anti-tumor effects in CIC-rearranged sarcoma},
author = {Quentin Odom-Lewis and Samantha L. Davis and Stephan Pieper and Shannon M. R. Legge and Emilia F. A. Regenfuss and Nicolas Fernandez and Phillip D. Michaels and João A. Paulo and Steven P. Gygi and Chen Chu and Shanshan Zheng and Paola Dal Cin and Jason L. Hornick and Nicole L. Solimini and Timothy B. Branigan and Mohamed Alyousef and Emanuele Mazzola and Ewa T. Sicinska and Karen Bui and Prafulla C. Gokhale and Christopher A. French and George D. Demetri and Geoffrey I. Shapiro and Inga-Marie Schaefer},
year = {2026},
journal = {Communications Medicine},
doi = {10.1038/s43856-026-01956-1},
url = {https://doi.org/10.1038/s43856-026-01956-1}
}RIS
TY - JOUR TI - Co-targeting CDK2 and CDK9 inhibits MYC oncogenic programs and has anti-tumor effects in CIC-rearranged sarcoma AU - Quentin Odom-Lewis AU - Samantha L. Davis AU - Stephan Pieper AU - Shannon M. R. Legge AU - Emilia F. A. Regenfuss AU - Nicolas Fernandez AU - Phillip D. Michaels AU - João A. Paulo AU - Steven P. Gygi AU - Chen Chu AU - Shanshan Zheng AU - Paola Dal Cin AU - Jason L. Hornick AU - Nicole L. Solimini AU - Timothy B. Branigan AU - Mohamed Alyousef AU - Emanuele Mazzola AU - Ewa T. Sicinska AU - Karen Bui AU - Prafulla C. Gokhale AU - Christopher A. French AU - George D. Demetri AU - Geoffrey I. Shapiro AU - Inga-Marie Schaefer PY - 2026 JO - Communications Medicine DO - 10.1038/s43856-026-01956-1 UR - https://doi.org/10.1038/s43856-026-01956-1 ER -
APA
Odom-Lewis, Q., Davis, S. L., Pieper, S., Legge, S. M. R., Regenfuss, E. F. A., Fernandez, N., Michaels, P. D., Paulo, J. A., Gygi, S. P., Chu, C., Zheng, S., Cin, P. D., Hornick, J. L., Solimini, N. L., Branigan, T. B., Alyousef, M., Mazzola, E., Sicinska, E. T., Bui, K., Gokhale, P. C., French, C. A., Demetri, G. D., Shapiro, G. I., & Schaefer, I. (2026). Co-targeting CDK2 and CDK9 inhibits MYC oncogenic programs and has anti-tumor effects in CIC-rearranged sarcoma. Communications Medicine. https://doi.org/10.1038/s43856-026-01956-1
Source records
- crossref · retrieved 2026-11-10T07:54:14.640Z